Analyst Price Targets — COWN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 16, 2026 12:34 pm | — | KeyBanc | $76.00 | $38.99 | StreetInsider | Forgent Power Solutions (FPS) PT Raised at TD Cowen on 'Upside 4Q Results and FY27 Guidance' |
| August 13, 2026 11:55 am | — | KeyBanc | $35.00 | $38.99 | StreetInsider | 'eToro Group (ETOR) Back To Show Me Status'; PT Lowered to $35 at TD Cowen |
| August 13, 2026 9:43 am | — | Wolfe Research | $34.00 | $38.99 | StreetInsider | Navan Inc (NAVN) PT Raised to $34 at TD Cowen |
| July 6, 2026 7:22 am | — | Cowen & Co. | $18.00 | $38.99 | StreetInsider | TD Cowen Upgrades Flagstar Bank (FLG) to Buy |
| July 6, 2026 7:22 am | — | RBC Capital | $18.00 | $38.99 | StreetInsider | TD Cowen Upgrades Flagstar Bank (FLG) to Buy |
| June 23, 2026 12:50 pm | — | Piper Sandler | $101.00 | $38.99 | StreetInsider | TD Cowen Reiterates Buy Rating on Block Inc. (XYZ) |
| June 5, 2026 12:38 pm | — | KeyBanc | $25.00 | $38.99 | StreetInsider | TD Cowen Reiterates Hold Rating on Brown Forman (BF-B) |
| June 5, 2026 11:54 am | — | UBS | $125.00 | $38.99 | StreetInsider | ServiceTitan (TTAN) PT Raised to $125 at TD Cowen Following Big 1Q Beat |
| June 2, 2026 12:22 pm | — | Wedbush | $28.00 | $38.99 | StreetInsider | Navan Inc (NAVN) PT Raised to $28 at TD Cowen; 'All Signs Point To A Healthy Beat & Raise' |
| March 13, 2026 1:28 pm | — | UBS | $135.00 | $38.99 | StreetInsider | ServiceTitan (TTAN) PT Raised to $135 at TD Cowen |
Latest News for COWN
TD Cowen initiated coverage of Space Exploration Technologies Corp (NASDAQ:SPCX) on Tuesday with a Buy rating. The firm argues that leasing AI computing capacity will soon become the company's biggest business.
CEO Michael Halstead to participate in a fireside chat on September 23, 2026 at 9:00 a.m. EDT CEO Michael Halstead to participate in a fireside chat on September 23, 2026 at 9:00 a.m. EDT
VANCOUVER, BC and BOSTON, MA, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced that the company will present at an upcoming investor conference:
INDIANAPOLIS, Sept. 17, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) ("Calumet") announced today that it plans to attend the T.D.
Amazon (NASDAQ:AMZN | AMZN Price Prediction) shares are trading at $258.63 as of Friday's close, down 2.47% over the past week but up 14.19% year to date.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for COWN.
U.S. House Trading
No House trades found for COWN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.